New York State extends multi-year ElliQ companion robot deployment to aging residents
New York's state aging agency extended its multi-year partnership deploying the ElliQ companion device to older residents at risk of isolation.
Full assessment3 claims · 3 technical notes · 2 sources

The extension follows three years of program data, including a reported drop in loneliness and over 3,500 applications in 2025.
WatchingFor an independent study of the loneliness figures, which so far are the program operator's own data.
The program's growth is documented; the loneliness figure behind it is the state's own report, not an independently verified clinical result.
On autonomy
- No hardware or software change accompanies this extension; the device itself is unchanged.
- ElliQ remains a stationary voice companion with no navigation or mobility capability.
On readiness
- A state agency scaled a companion device program after three years of outcome tracking.
- More than 3,500 people applied to the program in 2025, suggesting sustained demand.
- The agency reports a large self-reported drop in loneliness among participants.
3 maker claims checked against the record. Open one to read the finding.
A state-released figure reports a 95 percent reduction in loneliness among program participants.
88 percent of participants said the device improved their quality of life.
More than 3,500 people applied to the program in 2025.
2 sources · all linked
- 1Robotics & Automation News10 Oct 2026
- 2PR Newswire
Technical notes
3 sections
Program Scope
New York’s state aging services agency has renewed and extended its multi-year arrangement with the maker of the ElliQ companion device, continuing distribution of the stationary voice companion to older residents identified as at risk for loneliness and social isolation. The extension follows three years of program operation and was announced alongside outcome figures the agency released itself.
Reported Outcomes
The agency’s released data cites a 95 percent reduction in loneliness among participants and reports that 88 percent of users said the device improved their quality of life. More than 3,500 people applied to join the program in 2025 alone, which the agency points to as evidence of sustained demand beyond an initial pilot.
What Remains Unverified
The loneliness and quality-of-life figures are the program operator’s own self-reported outcome data, not findings from an independently conducted or peer-reviewed clinical study. No methodology, sample size or control comparison has been published alongside the figures. The device’s documented capabilities, including its stationary placement and subscription-gated features, are unchanged by this extension.




